Jon Coleman - 08 Mar 2026 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP, Chief Commercial Officer
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Jon Coleman
Issuer symbol
DXCM
Transactions as of
08 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 16:01:31 UTC
Previous filing
27 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coleman Jon EVP, Chief Commercial Officer 6430 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Jon Coleman 10 Mar 2026 0001442689

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award +43,897 +64% $0.000000* 112,635 08 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2 Included in this number are 112,635 unvested RSUs, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 68,738 of which were granted on May 22, 2025 and shall vest through May 22, 2029.

Remarks:

Exhibit 24 - Power of Attorney